Literature DB >> 11871278

The economics of kidney transplantation versus hemodialysis.

P R Loubeau1, J M Loubeau, R Jantzen.   

Abstract

Using 1998 data for 8 transplantation centers located in New York City, this study found that kidney transplantation was a more cost-effective treatment than hemodialysis for the Medicare program. The initially higher costs of transplantation were fully recouped by Medicare 2 years and 10 months after surgery. For persons who are eligible for Medicare solely due to their end-stage renal disease status, transplantation would generate average monthly savings of $3800 over dialysis for the 2 years following the break-even point. For those eligible for reasons other than end-stage renal disease, for example, the aged, the average savings would be $2400. The savings difference arises because Medicare coverage for immunosuppressants for the former group ends 36 months after transplantation.

Entities:  

Mesh:

Year:  2001        PMID: 11871278     DOI: 10.1177/152692480101100411

Source DB:  PubMed          Journal:  Prog Transplant        ISSN: 1526-9248            Impact factor:   1.065


  22 in total

Review 1.  Disparities in kidney transplant outcomes: a review.

Authors:  Elisa J Gordon; Daniela P Ladner; Juan Carlos Caicedo; John Franklin
Journal:  Semin Nephrol       Date:  2010-01       Impact factor: 5.299

2.  Residence location and likelihood of kidney transplantation.

Authors:  Marcello Tonelli; Scott Klarenbach; Braden Manns; Bruce Culleton; Brenda Hemmelgarn; Stefania Bertazzon; Natasha Wiebe; John S Gill
Journal:  CMAJ       Date:  2006-08-29       Impact factor: 8.262

3.  Ethnic advantages in kidney transplant outcomes: the Hispanic Paradox at work?

Authors:  Elisa J Gordon; Juan Carlos Caicedo
Journal:  Nephrol Dial Transplant       Date:  2008-12-15       Impact factor: 5.992

4.  The financial impact of immunosuppressant expenses on new kidney transplant recipients.

Authors:  Elisa J Gordon; Thomas R Prohaska; Ashwini R Sehgal
Journal:  Clin Transplant       Date:  2008-07-31       Impact factor: 2.863

Review 5.  A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy.

Authors:  Joseph Menzin; Lisa M Lines; Daniel E Weiner; Peter J Neumann; Christine Nichols; Lauren Rodriguez; Irene Agodoa; Tracy Mayne
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

6.  Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.

Authors:  Margaret E Helmuth; Qian Liu; Marc N Turenne; Jeong M Park; Murewa Oguntimein; Sarah K Dutcher; Rajesh Balkrishnan; Pratima Sharma; Jarcy Zee; Alan B Leichtman; Abigail R Smith
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-28       Impact factor: 8.237

7.  Sleeve Gastrectomy Compared with Gastric Bypass for Morbidly Obese Patients with End Stage Renal Disease: a Decision Analysis.

Authors:  Rashikh A Choudhury; Gerard Hoeltzel; Kas Prins; Eric Chow; Hunter B Moore; Peter J Lawson; Dor Yoeli; Akshay Pratap; Peter L Abt; Kristoffel R Dumon; Kendra D Conzen; Trevor L Nydam
Journal:  J Gastrointest Surg       Date:  2019-05-01       Impact factor: 3.452

8.  Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.

Authors:  Hui Zhang; Chao Zhang; Sufen Zhu; Hongjian Ye; Donglan Zhang
Journal:  BMC Health Serv Res       Date:  2020-02-14       Impact factor: 2.655

9.  Unintentional and intentional non-adherence to immunosuppressive medications in renal transplant recipients.

Authors:  Konstadina Griva; Hui Ling Michelle Neo; Anantharaman Vathsala
Journal:  Int J Clin Pharm       Date:  2018-06-06

Review 10.  Bioengineering in renal transplantation: technological advances and novel options.

Authors:  Wee-Song Yeo; Yao-Chun Zhang
Journal:  Pediatr Nephrol       Date:  2017-06-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.